[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Epidemiology](https://durgical.com/en/epidemiology/) › [US health system and quality (USMLE)](https://durgical.com/en/epidemiology/areas/us-system/) › USPSTF grades and cancer screening: US and Colombia

# USPSTF grades and cancer screening: US and Colombia

- US frame (USMLE)

The USMLE asks US ages; Colombian practice follows the [RIAS](https://durgical.com/en/epidemiology/comprehensive-health-care-pathways/). The same cancer can start at a different age on each side, so learn which exam asks which.

Updated Nov 19, 2026

## Key points

- A and B: offer or provide. C: offer selectively. D: discourage. I: insufficient evidence.
- Colorectal (USPSTF 2021): 50–75 grade A, 45–49 grade B, 76–85 grade C.
- Breast (USPSTF 2024): mammography every 2 years from 40 to 74 (B); 75 and over is I.
- [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/) (USPSTF 2018): cytology every 3 years from 21 to 29; from 30 to 65 cytology every 3, HPV every 5 or co-testing every 5.
- According to the RIAS: colorectal 50–75, mammography every 2 years 50–69, cytology 25–29, HPV DNA 30–65.
- USMLE answers use the USPSTF; Colombian practice follows [Resolution 3280](https://durgical.com/en/nursing/colombia-s-health-promotion-and-maintenance-route-from-the-nursing-side/) of 2018.

On this page

- The basics Key points
- What it is
- How to think about it
- Key facts
- Compared with Colombia’s SGSSS
- Worked example
- Average-risk cancer screening: USPSTF and the RIAS (Res. 3280 de 2018)
- Markers
- Common traps
- Elsewhere in DurgiPedia

- Study Test yourself

- Connections Connections

## What it is

The US Preventive Services Task Force (USPSTF) grades preventive services by the certainty and size of their net benefit: A and B mean offer or provide the service, C means offer it selectively to individuals, D means discourage it, and I means the evidence is insufficient to judge. Its current cancer screening recommendations start colorectal screening at 45 and run to 75, offer mammography every 2 years from 40 to 74, and screen the cervix from 21 to 65. In Colombia, Resolution 3280 of 2018 places cancer screening in the RIAS promotion and maintenance pathway, with its own ages and intervals.

## How to think about it

A grade reads two dials at once: how sure the Task Force is, and how big the benefit is once harms are subtracted. Sure and big is A, solid and moderate is B, small is C (a personal choice), harm at least equal to benefit is D, and dials too blurred to read is I. Two countries can read the same trials and still set different starting ages, because each weighs harms and resources for its own system.

## Key facts

- Grade A: high certainty of a substantial net benefit; offer or provide.
- Grade B: high certainty of a moderate net benefit, or moderate certainty of a moderate to substantial one; offer or provide.
- Grade C: at least moderate certainty of a small net benefit; offer selectively, by professional judgment and patient preference.
- Grade D: moderate or high certainty of no net benefit, or of harms outweighing benefits; discourage.
- Grade I: evidence lacking, poor or conflicting; if offered, patients should understand the uncertainty.

## Compared with Colombia’s SGSSS

- Colorectal: USPSTF from 45 to 75 (options include a yearly stool immunochemical test or colonoscopy every 10 years); according to the RIAS from 50 to 75, FIT every 2 years or colonoscopy every 10 years where available.
- Breast: USPSTF mammography every 2 years from 40 to 74; according to the RIAS a clinical breast exam at least yearly from 40 and a mammogram every 2 years from 50 to 69.
- Cervix: USPSTF cytology from 21, and from 30 to 65 cytology, HPV or co-testing; according to the RIAS cytology 25–29, HPV DNA every 5 years 30–65, and visual inspection 30–50 in dispersed areas.
- [Prostate](https://durgical.com/en/anatomy/prostate/): both frames make PSA an individual decision (USPSTF 55–69; RIAS 50–75 with a rectal exam, no more often than every 5 years).

## Worked example

- Made-up patient: Laura, 47, average risk, no symptoms, last cytology normal at 44.
- US frame: colorectal screening is due (B, 45–49), mammography every 2 years is due (B, from 40), and [cervical cytology](https://durgical.com/en/nursing/taking-a-cervical-cytology-or-hpv-sample-and-assisting-the-pelvic-examination/) is due again (every 3 years).
- RIAS frame: no colorectal screening yet (from 50) and no mammogram yet (from 50), but a yearly clinical breast exam (from 40) and an HPV DNA test (30–65).
- Mammograms in a lifetime of on-time screening: USPSTF every 2 years from 40 to 74 = 18; RIAS every 2 years from 50 to 68 = 10.
- Stool tests if that option is chosen: USPSTF yearly from 45 to 75 = 31; RIAS every 2 years from 50 to 74 = 13.
- Reading: on a USMLE question answer with the USPSTF age and grade; at a Colombian visit the RIAS applies. They weigh the same evidence differently.

## Average-risk cancer screening: USPSTF and the RIAS (Res. 3280 de 2018)

| Cancer | USPSTF (US) | RIAS (Colombia) | The difference to remember |
| --- | --- | --- | --- |
| Colorectal | 45–75 (A from 50, B 45–49); 76–85 C | 50–75: FIT every 2 years or colonoscopy every 10 years | US starts 5 years earlier and the stool test is yearly |
| Breast | Mammography every 2 years, 40–74 (B) | Clinical exam yearly from 40; mammogram every 2 years, 50–69 | US images from 40; Colombia from 50 and stops at 69 |
| Cervix | 21–29 cytology every 3 years; 30–65 cytology every 3, HPV every 5 or co-testing every 5 | 25–29 cytology every 3 years after a negative; 30–65 HPV DNA every 5 years | US starts at 21, Colombia at 25; both are HPV-based from 30 |
| Prostate | 55–69, individual decision | 50–75, PSA with rectal exam, informed decision, every 5 years at most | Both shared decisions; the age ranges differ |

## Markers

- USPSTF
- Grade A–D, I
- RIAS
- Res. 3280
- FIT
- HPV DNA test

## Common traps

- **Grade C means do not do it**: C means offer selectively, by judgment and preference; D is the grade that discourages
- **Grade I means the service is harmful**: I means the evidence is insufficient to weigh benefit against harm, not that harm is proven
- **Mammography starts at 50 on the USMLE**: since 2024 the USPSTF advises every 2 years from 40 to 74; 50–69 is the Colombian RIAS range
- **Colorectal screening starts at 50 in the US**: since 2021 the USPSTF starts at 45 (B), with 50–75 as grade A
- **HPV testing is fine from 21**: in the US under-30s are screened by cytology alone; HPV-based testing starts at 30 in both frames

## Test yourself

Think of the answer, then tap the question to see it.

## A 42-year-old US woman at average risk asks about mammography. What is the USPSTF answer, and how does the RIAS differ?

Every 2 years from 40 to 74 (grade B). The RIAS gives a yearly clinical breast exam from 40 but mammography every 2 years only from 50 to 69.

## A healthy 79-year-old asks about colorectal screening. Which grade applies, and what does it mean in practice?

Grade C (76–85): offer selectively, weighing prior screening, overall health and preference; it is neither routine nor discouraged.

## A 23-year-old asks for an HPV test. What does each frame say?

USPSTF: cytology every 3 years from 21; HPV-based testing starts at 30. RIAS: screening starts with cytology at 25 and HPV DNA at 30, so neither offers her an HPV test.

## Why can the US and Colombia set different starting ages from largely the same trials?

Each body weighs benefits, harms and resources for its own population and system; shared evidence can still lead to different thresholds.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/epidemiology/uspstf-grades-and-cancer-screening-us-and-colombia/)

## Elsewhere in DurgiPedia

- [The periodic health examination: what to check and screen at each age](https://durgical.com/en/clinical-exam/the-periodic-health-examination-what-to-check-and-screen-at-each-age/)
- [Cervical cancer screening with HPV testing in Colombia](https://durgical.com/en/obstetrics-gynaecology/cervical-cancer-screening-with-hpv-testing-in-colombia/)

## Connections

## Related 6

- [Cancer screening in adults by site: what Colombia offers](https://durgical.com/en/epidemiology/cancer-screening-in-adults-by-site-what-colombia-offers/)
- [Principles of screening](https://durgical.com/en/epidemiology/principles-of-screening/)
- [Comprehensive health care pathways (RIAS)](https://durgical.com/en/epidemiology/comprehensive-health-care-pathways/)
- [Overdiagnosis](https://durgical.com/en/epidemiology/overdiagnosis/)
- [Lead-time bias](https://durgical.com/en/epidemiology/lead-time-bias/)
- [How US health care is paid for](https://durgical.com/en/epidemiology/how-us-health-care-is-paid-for/)

## Related conditions 4

- [Colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)
- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)
- [Cervical cancer](https://durgical.com/en/conditions/cervical-cancer/)
- [Prostate cancer](https://durgical.com/en/conditions/prostate-cancer/)

[← All of epidemiology](https://durgical.com/en/epidemiology/)

Educational content on epidemiological and statistical methods; the examples use made-up numbers to teach the calculation. Not a clinical or legal guide: current Colombian rules are in the official sources.

Sources: [Grade Definitions | United States Preventive Services Taskforce](https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/grade-definitions) (U.S. Preventive Services Task Force, 2018); [Recommendation: Colorectal Cancer: Screening](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening) (U.S. Preventive Services Task Force, 2021); [Recommendation: Breast Cancer: Screening](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening) (U.S. Preventive Services Task Force, 2024); [Recommendation: Cervical Cancer: Screening](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening) (U.S. Preventive Services Task Force, 2018); [Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud (compiled text with the changes of Resolución 276 de 2019)](https://jurinfo.jep.gov.co/Normograma/Compilacion/docs/resolucion_minsaludps_3280_2018.htm) (Ministerio de Salud y Protección Social de Colombia (compiled text, JEP normograma), 2018).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/epidemiology/uspstf-grades-and-cancer-screening-us-and-colombia/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/epidemiology/uspstf-grades-and-cancer-screening-us-and-colombia/
